Skip to main content

Table 4 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus stage III-IV endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10

    

CHCA

    

M/z

pvalue

Mean Disease

Mean Control

Up/down

9774,53

0,014

0,596

1,098

down

14653,82

0,008

0,445

1,468

down

SPAhigh

    

14479,03

0,014

0,266

0,116

up

31793,90

0,036

1,596

0,142

up

SPAlow

    

8172,88

0,014

0,237

0,417

down

8388,16

0,036

0,126

0,362

down

9177,29

0,022

0,145

1,381

down

9399,55

0,036

0,180

0,415

down

9616,30

0,008

0,100

0,307

down

11477,23

0,014

0,058

0,167

down

12623,72

0,036

0,340

0,219

up

12787,28

0,036

0,036

0,132

down

15765,886

0,036

2,103

0,186

up

IMAC

    

CHCA

    

M/z

pvalue

Mean Disease

Mean Control

Up/down

6299,9273

0,008113117

0,23461589

0,47046801

down

9213,5098

0,01371083

0,362215739

1,57790751

down

9266,2242

0,022478873

0,695244394

1,44011883

down

9766,1943

0,035763767

0,764862056

0,35977499

up

15446,04

0,008

0,985

0,108

up

SPAhigh

    

9532,42

0,023

1,056

13,993

down

9767,55

0,036

1,436

4,258

down

13134,421

0,0137

0,23780214

0,53548423

down

SPAlow

    

7716,86

0,036

0,587

0,253

up

7832,06

0,036

0,204

0,369

down

8228,62

0,022

0,291

0,198

up

9190,0544

0,00811312

0,21041195

1,4064187

down